Preferred Name |
labetalol |
|
Synonyms |
kabetalol 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol 2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide |
|
Definitions |
This is any condition whose main influencing factor is labetalol, a salicylamide derivative that is a non-cardioselective blocker of beta-adrenergic receptors and alpha-1 adrenergic receptors used to treat high blood pressure. |
|
ID |
http://purl.obolibrary.org/obo/XCO_0001164 |
|
created_by |
slaulederkind |
|
creation_date |
2023-12-07T15:57:48Z |
|
database_cross_reference |
PMID:32119089 CID:3869 |
|
definition |
This is any condition whose main influencing factor is labetalol, a salicylamide derivative that is a non-cardioselective blocker of beta-adrenergic receptors and alpha-1 adrenergic receptors used to treat high blood pressure. |
|
has_exact_synonym |
kabetalol 3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol 2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide |
|
has_obo_namespace |
experimental_condition_ontology |
|
id |
XCO:0001164 |
|
label |
labetalol |
|
notation |
XCO:0001164 |
|
prefLabel |
labetalol |
|
treeView | ||
subClassOf |